This Nvidia Options Trade Could Return 600%

Summary

Jon Najarian discusses unusual Nvidia options activity, highlighting a call spread described as potentially returning 600% if NVDA rallies through $247. The segment also covers acquisition news, Vaxcyte's vaccine developments, market reactions to weaker jobs data, and MLB playoff action.

• An Nvidia call spread is described as potentially returning 600% if shares rally through $247.
• Morgan Stanley names Nvidia a top semiconductor pick with a $300 price target.
• Nvidia's stock-buyback authorization is highlighted as shares approach all-time highs.
• PTC reportedly surges roughly 36% after Schneider Electric agrees to acquire it at an approximately 42% premium.
• Vaxcyte reportedly jumps about 50% on vaccine developments, prompting discussion of its potential as an acquisition target.
• C.H. Robinson's multibillion-dollar deal for RXO is discussed as another sign of increasing acquisition activity.
• The Nasdaq rises following weaker-than-expected jobs data, while the VIX hovers near 16 and potential Federal Reserve policy implications are considered.

1. 0:00

   This Nvidia Options Trade Could Return 600% Nvidia is pushing toward another breakout—and options traders are already positioning for the move. On today's Rebel's Edge, Jon Najarian breaks down unusual options activity in Nvidia involving a call spread that could potentially return 600% if NVDA rallies through $247. The trade comes as Morgan Stanley names Nvidia a top semiconductor pick with a $300 price target and the stock pushes toward its all-time highs. Jon also discusses: The unusual options activity targeting another Nvidia breakout Why a move through $247 could produce a massive return on the call spread Morgan Stanley's $300 price target for NVDA Nvidia's massive stock-buyback authorization PTC surging roughly 36% after Schneider Electric agrees to acquire the company Why Schneider was willing to pay a roughly 42% premium for PTC Vaxcyte jumping about 50% on vaccine developments Whether Vaxcyte could eventually become an acquisition target C.H. Robinson's multibillion-dollar deal for RXO Why merger and acquisition activity appears to be heating up The Nasdaq moving higher following weaker-than-expected jobs data What the latest jobs numbers could mean for Federal Reserve policy The VIX continuing to hover near 16 Plus, Jon breaks down the latest action from the MLB playoffs. #RebelsEdge #Nvidia #NVDA #OptionsTrading #UnusualOptionsActivity #PTC #Vaxcyte #PCVX #StockMarket #Semiconductors

Transcript from the show's captions; automatic captions may contain errors. Educational content, not investment advice.